Orphan Drugs Market 2024-2028
Incremental Growth2024-2028 (US$bn)
$ 146.1
2024 Year-over-Year Growth
11.03%
CAGR (2024-2028)
11.62%
Report Coverage
Global
Orphan Drugs Market Segmentation
Market Segmentation & Scope
Market Segment by Geographic Landscape
39%
of the growth will originate
from North America
Global Market Size 2018 - 2028 (US$ Bn)
Market is segmented by Distribution Channel into Hospital Pharmacy, Specialty pharmacy, Retail pharmacy, Others
The Hospital Pharmacy is expected to be largest growing segment during 2024-2028
Largest Segment - Hospital pharmacy
US$ 342.50 Bn
Orphan Drugs Market by Distribution Channel into Hospital Pharmacy; 2018-2028 (US$ Bn)
Hospital Pharmacy Market Revenue and Forecast 2018-2028 (US$ Bn)Hospital Pharmacy
- Hospital Pharmacy Market Size and Forecast 2018 to 2028 (US$ Bn)
Orphan Drugs Market by Distribution Channel into Specialty pharmacy; 2018-2028 (US$ Bn)
Specialty pharmacy Market Revenue and Forecast 2018-2028 (US$ Bn)Specialty pharmacy
- Specialty pharmacy Market Size and Forecast 2018 to 2028 (US$ Bn)
Orphan Drugs Market by Distribution Channel into Retail pharmacy; 2018-2028 (US$ Bn)
Retail pharmacy Market Revenue and Forecast 2018-2028 (US$ Bn)Retail pharmacy
- Retail pharmacy Market Size and Forecast 2018 to 2028 (US$ Bn)
Orphan Drugs Market by Distribution Channel into Others; 2018-2028 (US$ Bn)
Others Market Revenue and Forecast 2018-2028 (US$ Bn)Others
- Others Market Size and Forecast 2018 to 2028 (US$ Bn)
Market is segmented by Product into Biologics, Non-biologics
The Biologics is expected to be largest growing segment during 2024-2028
Largest Segment - Biologics
US$ 543.20 Bn
Orphan Drugs Market Size by Segmentation, by Product (US$ Bn)
| Product | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biologics | 89.80 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Non-biologics | XX | 44.20 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Orphan Drugs Market by Product into Biologics; 2018-2028 (US$ Bn)
Biologics Market Revenue and Forecast 2018-2028 (US$ Bn)Biologics
- Biologics Market Size and Forecast 2018 to 2028 (US$ Bn)
Orphan Drugs Market by Product into Non-biologics; 2018-2028 (US$ Bn)
Non-biologics Market Revenue and Forecast 2018-2028 (US$ Bn)Non-biologics
- Non-biologics Market Size and Forecast 2018 to 2028 (US$ Bn)
Market is segmented by Geography into North America, Europe, Asia, ROW
The North America is estimated to contribute 39% to the growth of global market during the forecast period 2024-2028.
Largest Segment - North America
39%
Regional share of different regions, including North America, Europe, Asia, Rest of World (ROW)
| Region | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 57.30 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Europe | XX | 43.50 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Asia | XX | XX | 27.10 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| ROW | XX | XX | XX | 14.50 | 16.20 | XX | XX | XX | XX | XX | XX | XX |
Orphan Drugs Market Size by Geography into North America; 2018-2028 (US$ Bn)
North America Market Revenue and Forecast 2018-2028 (US$ Bn)Orphan Drugs Market Size by Country into Canada; 2018-2028 (US$ Bn)
Canada Market Revenue and Forecast 2018-2028 (US$ Bn)Orphan Drugs Market Size by Country into US; 2018-2028 (US$ Bn)
US Market Revenue and Forecast 2018-2028 (US$ Bn)Orphan Drugs Market Size by Geography into Europe; 2018-2028 (US$ Bn)
Europe Market Revenue and Forecast 2018-2028 (US$ Bn)Orphan Drugs Market Size by Country into Germany; 2018-2028 (US$ Bn)
Germany Market Revenue and Forecast 2018-2028 (US$ Bn)Orphan Drugs Market Size by Country into UK; 2018-2028 (US$ Bn)
UK Market Revenue and Forecast 2018-2028 (US$ Bn)Orphan Drugs Market Size by Geography into Asia; 2018-2028 (US$ Bn)
Asia Market Revenue and Forecast 2018-2028 (US$ Bn)Orphan Drugs Market Size by Country into China; 2018-2028 (US$ Bn)
China Market Revenue and Forecast 2018-2028 (US$ Bn)Orphan Drugs Market Size by Geography into ROW; 2018-2028 (US$ Bn)
ROW Market Revenue and Forecast 2018-2028 (US$ Bn)Major Companies
Market Companies
| Name | Profile | Employees | Headquarters | Website | |
|---|---|---|---|---|---|
| AbbVie Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Alnylam Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Astellas Pharma Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| bluebird bio Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| CSL Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Gilead Sciences Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| GlaxoSmithKline Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Ipsen Pharma | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Johnson and Johnson Services Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Merck and Co. Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novo Nordisk AS | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Ractigen Therapeutics | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Takeda Pharmaceutical Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Vertex Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Orphan Drugs Market Scope
- By Distribution Channel
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Distribution Channel, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Distribution Channel, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2022
- Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2028
- By Product
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Product, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Product, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
- Absolute $ Opportunity Analysis By Product, 2024 to 2028
- By Region
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Region, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Region, 2024 to 2028
- North America Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Distribution Channel
- By Product
- Europe Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Distribution Channel
- By Product
- Asia Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Distribution Channel
- By Product
- Rest of World (ROW) Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Distribution Channel
- By Product
Major Companies
Market companies
| Name | Profile | Employees | Headquarters | Website | |
|---|---|---|---|---|---|
| AbbVie Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Alnylam Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Astellas Pharma Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| bluebird bio Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| CSL Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Gilead Sciences Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| GlaxoSmithKline Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Ipsen Pharma | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Johnson and Johnson Services Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Merck and Co. Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novo Nordisk AS | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Ractigen Therapeutics | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Takeda Pharmaceutical Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Vertex Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Subscribe to World-Class Market Intelligence
Basic Plan
Experience the best of reports & insights
